These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3034846)

  • 41. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
    Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143a.
    Huang L; Rowin G; Dunn J; Sykes R; Dobna R; Mayles BA; Gross DM; Burg RW
    J Antibiot (Tokyo); 1984 May; 37(5):462-5. PubMed ID: 6203886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-converting enzyme inhibitory activity of Lactobacillus helveticus strains from traditional fermented dairy foods and antihypertensive effect of fermented milk of strain H9.
    Chen Y; Liu W; Xue J; Yang J; Chen X; Shao Y; Kwok LY; Bilige M; Mang L; Zhang H
    J Dairy Sci; 2014 Nov; 97(11):6680-92. PubMed ID: 25151888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl] -(1S,3S,5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498).
    Becker RH; Schölkens BA; Metzger M; Schulze KJ
    Arzneimittelforschung; 1984; 34(10B):1411-6. PubMed ID: 6097267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors.
    Meyer RF; Nicolaides ED; Tinney FJ; Lunney EA; Holmes A; Hoefle ML; Smith RD; Essenburg AD; Kaplan HR; Almquist RG
    J Med Chem; 1981 Aug; 24(8):964-9. PubMed ID: 6173481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihypertensive and cardioprotective effects of the dipeptide isoleucine-tryptophan and whey protein hydrolysate.
    Martin M; Kopaliani I; Jannasch A; Mund C; Todorov V; Henle T; Deussen A
    Acta Physiol (Oxf); 2015 Dec; 215(4):167-76. PubMed ID: 26297928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of angiotensin-converting enzyme by dipeptide analogs.
    Schwab A; Macerata R; Rogers W; Barton J; Skiles J; Khandwala A
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):339-45. PubMed ID: 6095384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia.
    Mojaverian P; Swanson BN; Ferguson RK
    Eur J Pharmacol; 1984 Feb; 98(2):303-6. PubMed ID: 6325220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
    Trippodo NC; Robl JA; Asaad MM; Bird JE; Panchal BC; Schaeffer TR; Fox M; Giancarli MR; Cheung HS
    J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4.
    Yamamoto N; Maeno M; Takano T
    J Dairy Sci; 1999 Jul; 82(7):1388-93. PubMed ID: 10416158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and structure-activity relationships of potent new angiotensin converting enzyme inhibitors containing saturated bicyclic amino acids.
    Blankley CJ; Kaltenbronn JS; DeJohn DE; Werner A; Bennett LR; Bobowski G; Krolls U; Johnson DR; Pearlman WM; Hoefle ML
    J Med Chem; 1987 Jun; 30(6):992-8. PubMed ID: 3035180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis.
    Je JY; Park PJ; Byun HG; Jung WK; Kim SK
    Bioresour Technol; 2005 Sep; 96(14):1624-9. PubMed ID: 15978996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.
    Saito S; Matsui S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 Mar; 40(3):257-60. PubMed ID: 2346534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketomethyldipeptides II. Effect of modifications of the alpha-aminoketone portion on inhibition of angiotensin converting enzyme.
    Gordon EM; Natarajan S; Pluscec J; Weller HN; Godfrey JD; Rom MB; Sabo EF; Engebrecht J; Cushman DW
    Biochem Biophys Res Commun; 1984 Oct; 124(1):148-55. PubMed ID: 6093783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
    Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
    Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
    Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.